Brief: Mirum Pharmaceuticals Q1 Product Sales USD 111.585 Million
07/05/2025 21:01
May 07 (Reuters) - Mirum Pharmaceuticals Q1 operating expenses USD 126.768 million. Q1 basic EPS USD -0.3 Q1 net income USD -14.677 million Q1 operating income USD -15.183 million
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX